ReCode Therapeutics is a genetic medicines company that uses precision delivery to develop mRNA and gene correction therapeutics, with a focus on treatments for primary ciliary dyskinesia, cystic fibrosis, and other genetic diseases.

ViaNautis Bio specializes in nano-engineered polymer technology, PolyNaut®, which enables targeted intracellular delivery of therapeutic payloads.

Arcturus Therapeutics is developing an inhaled mRNA therapy for cystic fibrosis, delivering the mRNA template to lung cells using a lipid nanoparticle.